Atilano, Rivalle Eren I.
HRN: 16-01-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2022
CEFTRIAXONE 1G (VIAL)
05/01/2022
05/07/2022
IV
1.5g
Once A Day
Acute Tonsillitis, T/c Dengue Fever, URTI
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Urinary TractURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes